DFC Support Program – National Community Anti-Drug Coalition Institute (NCI)
ID: 355995Type: Posted
Overview

Buyer

Office of National Drug Control Policy (ONDCP)

Award Range

$0 - $3M

Eligible Applicants

Nonprofits Without 501(c)(3) Status

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355995

Additional Information

https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=113144
Timeline
    Description

    The Office of National Drug Control Policy is offering a federal grant opportunity titled "DFC Support Program – National Community Anti-Drug Coalition Institute (NCI)." This program aims to enhance the capacity of the prevention workforce and community coalitions to implement evidence-based interventions aimed at preventing substance use among adolescents, particularly during the critical ages of 12 to 19. The initiative recognizes the importance of early prevention efforts in reducing the likelihood of substance use disorders later in life, thereby promoting health and social benefits. The total estimated funding for this grant is $2,500,000, with a maximum award ceiling of $2,500,000 and no minimum award amount. Interested applicants, specifically nonprofits without 501(c)(3) status, must submit their proposals by September 16, 2024, and can reach out to the Grants.gov Customer Support at support@grants.gov for further assistance.

    Point(s) of Contact
    support@grants.gov
    Files
    No associated files provided.
    Similar Opportunities
    Drug-Free Communities (DFC) Support Program - NEW (Year 1)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC), through the National Center for Injury Prevention and Control (NCIPC), is forecasting the availability of grants under the Drug-Free Communities (DFC) Support Program for Fiscal Year 2025. This program aims to establish and strengthen community coalitions focused on preventing youth substance use, with the overarching goals of fostering collaboration among various stakeholders and reducing substance abuse among youth and adults. Eligible applicants include nonprofit organizations with 501(c)(3) status, community-based coalitions, and other entities that support these initiatives, with a total estimated funding of $62.5 million and an award ceiling of $125,000 per grant. Interested parties should note that applications must be submitted electronically by March 25, 2025, and can direct inquiries to Brandis Belser at dfcnofo@cdc.gov.
    Drug-Free Communities (DFC) Support Program - Competing Continuation (Year 6)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC), through the National Center for Injury Prevention and Control (NCIPC), is forecasting the availability of grants under the Drug-Free Communities (DFC) Support Program for Fiscal Year 2025. This program aims to establish and strengthen collaborations among community coalitions to prevent and reduce substance use among youth, specifically targeting individuals aged 18 and younger. Eligible applicants include community-based coalitions that have previously received DFC funding and are either resuming after a lapse or entering a second five-year funding cycle. The total estimated funding for this opportunity is $12.5 million, with individual awards ranging from $0 to $125,000, and approximately 100 awards expected to be made. Interested parties should note that applications must be submitted electronically by March 31, 2025, with an anticipated award date of August 29, 2025. For further inquiries, applicants can contact Brandis Belser at dfcnofo@cdc.gov.
    Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at the development of medications to prevent and treat opioid and stimulant use disorders and overdose. This initiative seeks innovative preclinical and clinical research projects that can lead to FDA-approved therapies, focusing on areas such as prevention of substance use initiation, treatment adherence, and reduction of overdose risks. With a maximum funding amount of $3 million per year over a project period of five years, applicants are encouraged to submit proposals that demonstrate their capability to manage the research effectively, adhering to detailed application instructions. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for September 1, 2025.
    Strategic Prevention Framework – Partnerships for Success for Communities, Local Governments, Universities, Colleges, and Tribes/Tribal Organizations
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "Strategic Prevention Framework – Partnerships for Success for Communities, Local Governments, Universities, Colleges, and Tribes/Tribal Organizations." This program aims to reduce the onset and progression of substance misuse and related issues by enhancing community-based prevention and mental health promotion services, thereby strengthening local prevention providers' capacity to implement evidence-based programs. With an estimated total program funding of $15,500,000 and an expected 41 awards, the grant has a funding ceiling of $375,000 and is open for applications for FY 2024 and FY 2025, with deadlines on February 26, 2024, and February 21, 2025, respectively. Interested applicants can reach out to the Office of Financial Resources at SAMHSA via email at FOACSAP@samhsa.hhs.gov for further information.
    NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering the P50 Research Center of Excellence Grant Program to support innovative research in substance use and addiction. This program aims to establish multidisciplinary research centers that not only advance scientific knowledge but also serve as national resources for education and outreach within the drug abuse research community. The initiative encourages applications that focus on integrated themes rather than incremental work, with a budget limit of $10 million over five years and a maximum of 25% of direct costs allocated to pilot projects. Interested applicants should note that the submission process requires adherence to specific guidelines, including a Plan for Enhancing Diverse Perspectives (PEDP), and key deadlines extend until November 18, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity titled "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)" aimed at accelerating the development of medications for Substance Use Disorders (SUDs). This initiative encourages research applications for diverse preclinical and clinical projects that can expedite the FDA approval process for new treatments, addressing the significant public health need for effective therapies for conditions such as cocaine, methamphetamine, and cannabis use disorders. The program will provide cooperative agreements for projects lasting up to three years, with annual budgets capped at $5 million, and applications are accepted on a rolling basis with specific due dates for scientific merit review established throughout 2023 and 2024. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-202.html.
    Sober Truth on Preventing Underage Drinking Act (STOP Act) Grant Program
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting the availability of the Sober Truth on Preventing Underage Drinking Act (STOP Act) Grant Program, aimed at preventing and reducing alcohol use among youth and young adults aged 12-20 across the United States. This grant program seeks to address various factors related to underage drinking, including social norms, enforcement efforts, and penalties, while building on strategic plans developed under previous Drug Free Communities (DFC) grants. With an estimated total program funding of $749,000 and an expected 12 awards, eligible applicants include domestic public and private nonprofit entities that are current or former DFC Support Program recipients. Interested parties can reach out to Jerry Campbell at (240) 276-0117 or via email at CSAP.DPP@samhsa.hhs.gov for further information, with the synopsis expected to be posted on November 15, 2024.
    Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials," aimed at encouraging pilot research to develop and test interventions that prevent or delay substance use. The initiative focuses on the creation and pilot testing of new or adapted strategies to curb substance misuse, particularly among underserved populations, while also addressing related negative outcomes such as impaired driving and transmission of infectious diseases. Eligible applicants include a wide range of institutions, such as academic, nonprofit, and government organizations, with funding available up to $450,000 over three years. Interested parties should note that applications are due starting January 16, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    Strategic Prevention Framework – Partnerships for Success for States
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "Strategic Prevention Framework – Partnerships for Success for States." This program aims to reduce the onset and progression of substance misuse by supporting the development and delivery of state and community prevention services, thereby enhancing the capacity of local providers to implement evidence-based programs. The grant is particularly significant for states, U.S. Territories, Pacific Jurisdictions, and the District of Columbia, with a total estimated funding of $15.5 million and an award ceiling of $1.25 million for up to 12 awards. Interested applicants should note that applications for FY 2024 are due by February 26, 2024, and for FY 2025 by February 2, 2025. For further inquiries, applicants can contact the Office of Financial Resources at SAMHSA via email at FOACSAP@samhsa.hhs.gov or by phone at 240-276-1940.
    Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity for the development of medications aimed at preventing and treating substance use disorders (SUDs) and overdose. This initiative is structured into two phases: the UG3 phase focuses on achieving specific milestones within a two-year period, while the UH3 phase extends support for an additional three years for projects that successfully meet the UG3 milestones. Given the urgent need for effective treatments in light of rising overdose deaths, particularly from synthetic opioids and stimulants, this funding opportunity emphasizes innovative research methodologies and the effective application of existing medications. Interested applicants can seek funding of up to $3 million annually for a maximum of five years, with applications due by August 11, 2025. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-329.html.